Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Catheter Ablation Using a Novel Navigation and Imaging System

NCT: NCT06895187 · NOT_YET_RECRUITING

NCT IDNCT06895187
StatusNOT_YET_RECRUITING
Start Date2027-01-01
Completion2027-12-01
SponsorLUMA Vision Ltd. (INDUSTRY)
First posted
Last updated

Brief Summary

The objective of the ENVIsIoN study is to collect data on the use of the VERAFEYE navigation and imaging system in patients indicated to undergo a catheter ablation procedure for the treatment of Paroxysmal Atrial Fibrillation (PAF).

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑